<DOC>
	<DOCNO>NCT02637193</DOCNO>
	<brief_summary>The purpose study demonstrate lack effect venlafaxine ( Effexor XR ) QTc interval relative time match placebo healthy volunteer</brief_summary>
	<brief_title>A Study Assess The Effects Of Effexor XR On Cardiac Repolarization In Healthy Adult Subjects</brief_title>
	<detailed_description>This single-center , randomize , double-blinded , placebo- moxifloxacin-controlled , 3 period , 6-sequence , 3 treatment ( venlafaxine placebo blind ; moxifloxacin open label ) , 3-way crossover thorough QT ( TQT ) study effect venlafaxine cardiac repolarization approximately 54 healthy subject</detailed_description>
	<mesh_term>Venlafaxine Hydrochloride</mesh_term>
	<mesh_term>Moxifloxacin</mesh_term>
	<mesh_term>Fluoroquinolones</mesh_term>
	<mesh_term>Norgestimate , ethinyl estradiol drug combination</mesh_term>
	<criteria>Main 1 . Healthy female subject and/or male subject time screening , age 18 55 year , inclusive . Healthy define clinically relevant abnormality identify detailed medical history , full physical examination , include blood pressure pulse rate measurement , 12 lead ECG clinical laboratory test . 2 . Body Mass Index ( BMI ) 17.5 30.5 kg/m2 ; total body weight &gt; 50 kg ( 110 lb ) . 3 . Evidence personally sign date informed consent document indicate subject inform pertinent aspect study . 4 . Subjects willing able comply schedule visit , treatment plan , laboratory test , study procedure . 5 . Based CYP2D6 genotyping , subject require classified CYP2D6 extensive metabolizer ( EM ) . Main 1 . Evidence history clinically significant hematological , renal , endocrine , pulmonary , gastrointestinal , cardiovascular , hepatic , psychiatric , neurologic , allergic disease ( include drug allergy , exclude untreated , asymptomatic , seasonal allergy time dose ) . 2 . Any condition possibly affect drug absorption ( eg , gastrectomy ) . 3 . A positive urine drug screen . 4 . History regular alcohol consumption exceed 7 drinks/week female 14 drinks/week male ( 1 drink = 5 ounce ( 150 mL ) wine 12 ounce ( 360 mL ) beer 1.5 ounce ( 45 mL ) hard liquor ) within 6 month Screening . 5 . Treatment investigational drug within 30 day ( determined local requirement ) 5 half life precede first dose study medication ( whichever longer ) . 6 . Screening supine blood pressure &gt; 140 mm Hg ( systolic ) &gt; 90 mm Hg ( diastolic ) , follow least 5 minute rest . If BP &gt; 140 mm Hg ( systolic ) &gt; 90 mm Hg ( diastolic ) , BP repeat two time average three BP value use determine subject 's eligibility . 7 . Screening supine 12 lead ECG demonstrate QTcF &gt; 450 msec QRS interval &gt; 120 msec . If QTcF exceed 450 msec , QRS exceed 120 msec , ECG repeat two time average three QTcF QRS value use determine subject 's eligibility . 8 . Pregnant female subject ; breastfeed female subject ; male subject partner currently pregnant ; male subject able father child female subject childbearing potential unwilling unable use 2 highly effective method contraception outline protocol duration study least 28 day last dose investigational product longer base upon compound 's halflife characteristic . 9 . Use prescription nonprescription drug dietary supplement within 7 day 5 half life ( whichever longer ) prior first dose study medication . 10 . As exception , acetaminophen/paracetamol may use dos less 1 g/day . Limited use non prescription medication believe affect subject safety overall result study may permit case case basis follow approval sponsor . Herbal supplement hormone replacement therapy must discontinue least 28 day prior first dose study medication . 11 . Blood donation ( exclude plasma donation ) approximately 1 pint ( 500 mL ) within 56 day prior dose . 12 . History sensitivity heparin heparin induce thrombocytopenia . 13 . History known QTc prolongation ECG abnormality . 14 . Individuals know hypersensitivity reaction venlafaxine , desvenlafaxine SSRI ( Selective serotonin reuptake inhibitor ) SNRI ( Selective serotonin norepinephrine reuptake inhibitor ) . 15 . Individuals know hypersensitivity moxifloxacin quinolones .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>August 2016</verification_date>
</DOC>